Allergan Launches Juvéderm® VOLITE - An Innovative Injectable Treatment Designed to Improve Skin Quality for up to 9 Months

Dublin (ots/PRNewswire) - -- Allergan enters skin quality category
with new injectable product using VYCROSS® technology[1] for use on
the face, neck, décolletage and hands[2]

-- Hyaluronic Acid (HA) gel designed to improve skin's smoothness
(absence of fine lines), hydration and elasticity for up to nine
months with just one treatment[3]

-- Global research shows more than half of women say appearance of
skin contributes to their outer beauty[4]

Allergan plc (NYSE: AGN), a leading global pharmaceutical company,
announced today its entry into the skin quality category with the
launch of Juvéderm® VOLITE.[2] This is Allergan's first injectable
product specifically designed to improve skin quality[5] and last up
to nine months with just one treatment session.[3] This innovative
new Allergan product uses the unique patented VYCROSS® technology.[1]

A new innovation for skin quality

The new HA injectable treatment delivers improvements in skin
smoothness (absence of fine lines), hydration and elasticity,[2] and
is designed to last for up to nine months with just one treatment.[3]
Clinical data so far has shown significant improvements in skin
quality for up to 6 months, and the clinical study is ongoing.[6],[7]
Juvéderm® VOLITE aims to deliver results that last and eliminate the
need for multiple treatments.[3] It should be injected intradermally
and can be used to treat the face, neck, décolletage and hands and
contains the anaesthetic lidocaine, to enhance patient comfort.[2]

Dr Patricia Ogilvie, Leading Dermatologist, Germany, says: "Juvéderm®
VOLITE answers a real need for a treatment that delivers a
healthy-looking glow. Combined with the fact that only one treatment
is needed to achieve results, this product will be a game changer in
my clinic. I believe that great skin can have a profound impact on
patients' everyday lives - in particular their confidence. It goes
far beyond aesthetics - when a patient is happy with how they look on
the outside, this affects how they feel on the inside. Juvéderm®
VOLITE is a genuinely innovative treatment option that I'm excited to
be able to offer my patients."

For more information and to read the rest of this press release
please go to:
http://www.allergan.com/news/news/allergan-launches-juvederm-volite

Contact:

Janet Kettels, +44-7738-506-476

Karen Dennehy, +44-7824-017-950

ORIGINAL APA-OTS TEXT - THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS SUBJECT TO THE EXCLUSIVE RESPONSIBILITY OF THE ISSUER | PRN

print